Calumet, Inc. (CLMT) intrinsic value & 10-year financials
Calumet, Inc. (CLMT) has a Graham intrinsic value of $0.19 per share. At $57.75 on Oct 17, 2026, the stock trades 30295% above that value. Over the last 5 fiscal years revenue shrank 4.1% a year to $4.1B, with an average return on invested capital of -1.1%.
- Graham intrinsic value
- $0.19
- Share price (Oct 17, 2026)
- $57.75
- Price vs Graham value
- 30295% above
- Market cap
- $5.0B
- Revenue (FY2025)
- $4.1B
- Revenue growth (5-yr CAGR)
- -4.1%
- ROIC (10-yr avg)
- -1.1%
- Free cash flow (FY2025)
- $56.6M
CLMT 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $4.1B | -$33.8M | -$0.39 | $56.6M | 2.6% | 4.3% |
| FY2024 | $4.2B | -$222.0M | -$2.67 | -$123.1M | 0.2% | 0.6% |
| FY2023 | $4.2B | $48.1M | — | -$286.7M | 6.4% | 19.4% |
| FY2022 | $4.7B | -$173.3M | — | -$435.6M | 2.8% | -28.7% |
| FY2021 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Calumet, Inc. /DE revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Calumet, Inc. /DE has historically struggled to out-earn its cost of capital, averaging just -1.1% ROIC.
Calumet, Inc. /DE capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Calumet, Inc. /DE is modeled at -4.1% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $0.19 per share.